BBVA, Spain's second-largest lender by market capitalization, operates across diverse geographies including Europe, Mexico, Turkey, and South America. The 1Q26 earnings (covering January to March 2026) come amid peaking interest rates that have bolstered NII but also heightened provisioning needs due to economic uncertainties. For investors like myself, these results signal BBVA's execution on its diversification strategy and resilience in volatile markets. Strong profitability and capital levels underscore its appeal in a sector facing margin pressures, while buyback announcements highlight shareholder-friendly policies amid geopolitical tensions.
BBVA delivered standout 1Q26 results, with net attributable profit of €2.99 billion surpassing analyst forecasts of €2.79 billion and growing 10.8% YoY (14.1% at constant FX). Gross income surged 18.3% to €10.65 billion, driven by NII of €7.54 billion (+20.2% YoY, margin at 3.35%) and net fees & commissions of €2.26 billion (+15.5% YoY). Core revenues reached €9.79 billion (+19.1%), while operating income was €6.60 billion (+18.7%).
Expenses grew 17.5% YoY, yielding an efficiency ratio of 38% (improved 24 basis points). Provisions increased 35% to €1.82 billion amid higher risk, but non-performing loans stayed at 2.6% with coverage at 86%. Profitability shone with ROTE at 21.7% and EPS up 12.5% YoY. Balance sheet strength persisted, with CET1 at 12.83% (+13 bps quarter-on-quarter) and loans +17% YoY. All major metrics beat expectations, validating BBVA's business model. One thing that stands out to me is how these figures compare to peers—I also checked this using Tickeron’s AI Screener to see BBVA alongside others in the industry.
BBVA's earnings beat sparked positive initial reactions, with analysts highlighting resilient revenues and capital returns amid rising provisions. Madrid-listed shares edged higher in early trading, while the NYSE ADR held steady in pre-market, reflecting approval of the 21.7% ROTE and buyback news. Investor sentiment remains bullish, with consensus ratings at "Buy" and praise for diversification across high-growth regions like Mexico and Turkey. Concerns over provisions were offset by stable asset quality. From what I see, this positions BBVA well for continued interest.
One tool I rely on regularly for my analysis is Tickeron’s AI Screener, an AI-powered stock and ETF discovery tool that helps me filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. I use it to scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It uncovers trade ideas, trending stocks, breakout candidates, and market opportunities far more efficiently than manual screening, and it’s become a staple in my research workflow for stocks like BBVA.
Investors should track BBVA's ongoing share repurchase program, with the new €1.46 billion tranche starting May 6, potentially totaling nearly €4 billion since December. This supports tangible book value growth (+18.1% YoY excluding buybacks) and aligns with commitments to distribute excess capital above the 11.5%-12% CET1 target. I’m watching this closely as it demonstrates BBVA's commitment to shareholders.
Progress toward the 2028 strategic plan goals, including sustained 20%+ ROTE, remains key. Management affirmed on-track execution, bolstered by AI integration across eight initiatives to drive efficiency.
Watch loan portfolio dynamics: +17% growth signals demand, but monitor non-performing loans (2.6%) and cost of risk (1.54%) amid economic headwinds in Europe and LatAm. NII trajectory will depend on rate paths, while fee income from diversification in Türkiye and South America offers upside. Geopolitical risks and regulatory changes in key markets warrant attention. In my view, these elements will shape BBVA's path forward.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
The 10-day moving average for BBVA crossed bullishly above the 50-day moving average on April 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where BBVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on May 07, 2026. You may want to consider a long position or call options on BBVA as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
BBVA moved above its 50-day moving average on May 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BBVA advanced for three days, in of 343 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 362 cases where BBVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for BBVA moved out of overbought territory on April 20, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 54 similar instances where the indicator moved out of overbought territory. In of the 54 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for BBVA turned negative on April 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BBVA broke above its upper Bollinger Band on April 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 30, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BBVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.852) is normal, around the industry mean (1.467). P/E Ratio (10.257) is within average values for comparable stocks, (13.156). Projected Growth (PEG Ratio) (1.869) is also within normal values, averaging (3.677). Dividend Yield (0.049) settles around the average of (0.039) among similar stocks. P/S Ratio (2.623) is also within normal values, averaging (3.694).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks